Patients eligible for PCI with application of DES, due to ACS.
Patients with known or newly diagnosed T2D (type 2 diabetes is diagnosed according to current WHO criteria or by the use of anti-diabetic drugs)
Male and female subjects 18-80 years.
HbA1c (accordingly to IFCC) 47 mmol/mol - 110 mmol/mol.
Signed informed consent form.

NCT02621489_inc_T1
Procedure
PCI
NCT02621489_inc_T2
Procedure
DES
NCT02621489_inc_T3
Condition
ACS
NCT02621489_inc_T4
Condition
T2D
NCT02621489_inc_T5
Person
Male
NCT02621489_inc_T6
Person
female
NCT02621489_inc_T7
Person
years
NCT02621489_inc_T8
Value
18-80
NCT02621489_inc_T9
Measurement
HbA1c
NCT02621489_inc_T10
Value
47 mmol/mol - 110 mmol/mol